chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started having chest pain after my first vaccine on 03-23-2021 but it was fine.  I received my second dose on 04-03-2021 and on     05-24-2021, I had severe chest pain, thought I was cardiac arrest so I went to ER was admitted on 05-24-2021. I also contacted my doctor which I was seeing for the Covid. I had severe Covid in October in 2020 while taking care of a patient in ICU. I was taking Cardizem (Diltiazem) in March 2021. I had to do a stress test, had to do a cardiac catheter and was at the hospital for a week along with the Cardizem and now I am on two heart medications. The second medication is Isosorbide and was started on this medication on 05-27-2021.  My heart rate also shoots up and having tachycardia.  Today I am still doing treatment and still taking my medication and still off of work.
Nausea upon waking, no vomit, passed out, profuse sweating. Feeling ill most of the day. Slow recovery next day.
Allergic reaction to my right eye; This is a spontaneous report from a contactable consumer (patient).A 34-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Mar2021 at 08:00 (Batch/Lot number was not reported, Expiry date not reported) (at the age of 34-years-old) as dose 2, single for COVID-19 immunization. The patient did not had any medical history and no allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient has not been tested for COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Feb2021 at 09:15 (Batch/Lot number was not reported, Expiry date not reported) as dose 1, single for COVID-19 immunization. On 15Mar2021 at 20:00, the patient experienced allergic reaction to right eye. It was reported that Same thing happened to her sister who got the shot at the same time. No treatment received for the adverse event. The patient had not yet recovered from the event.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021289428 same reporter/drug/AE with different patient
Patient reported stiffness in the neck and muscle pain around injection site. Pt also developed redness around the injection site and down the arm. Pt also developed a mild fever.
About 20 minutes after shot  a little dizzy, arms and legs tingly. Subsided, but tingling in arms returned about an hour later, though not as severe
Information has been received from a registered nurse concerning a female registered nurse who on March 27, 2003 was administering MMR II to a patient and the patient's mother bumped the nurse's hand, the needle came out of the patient's arm and some of the vaccine went into the nurse's eye. Unspecified medical attention was sought. Additional information has been requested.
A rash developed within the first 24 hours of receiving the Fluad Quad 20-21 vaccine on the upper, right arm around the injection site.  The patient had several patches (5 or 6) that were red and formed blisters. There were no other issues.
The report was first received from practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 05-DEC-2017 and 08-FEB-2018, the patient was vaccinated with ROTATEQ (strength were unknown) (lot # N004815 and expiration date 07-OCT-2018; lot # N003984 and expiration date 19-NOV-2018) 1 dose form orally for prophylaxis. No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017 and 23-JAN-2018 was 47 degree Celsius for max 15 hours. And on 07-DEC-2017 was 50 degree Celsius for max 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001958.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown demographics. On an unknown date, the patient was vaccinated with a dose of improperly stored GARDASIL (Lot number, expiry date, route and dose were not reported). The certified medical assistant reported that the vaccine was exposed to temperature of 26 F (Fahrenheit) for a total of 135 hours. No adverse effects reported. Follow-up received. Certified medical assistant stated that other 104 children received GARDASIL. Follow up information has been received from the certified medical assistant regarding an unknown age, male patient with no pertinent medical history reported. On 24-AUG-2012 the patient was vaccinated with a dose of GARDASIL (lot number and expiration date not reported) (dose and route not reported). On 28-DEC-2012 the patient received another dose of GARDASIL (lot number and expiration date not reported) (dose and route not reported). It was reported that the patient did not seek medical attention. It was also reported that the patient did not have any illness at the time of vaccination. This is one of the several reports from the same source. Additional information is not expected.
Severe headache w/i 2 1/2 hrs, dizziness with nausea, hard chills, fever 101.2. Excessive thirst 4+ hrs. Chills intermittent 2 hr. Sx 48 hours with extreme fatigue for 3 days.
3 hours after vaccination "everything went black" which lasted a couple seconds. Then patient states her face was purple, which lasted 5-6 hours. After this time no other symptoms occurred.
Developed hives within 4 hours of vaccination. Has taken benadryl and claritin. Present to me today with hives covering the trunk and neck. Treated with prednisone
On 12/24/01, a rash started with a fever. On 12/27/01, saw doctor and had a temperature of 103F with a measles-like rash.
postherpetic neuralgia; multiple outbreaks of herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unspecified age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot number, dosage and route of administration not provided) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). After receiving zoster vaccine live (ZOSTAVAX), the patient suffered multiple outbreaks of herpes zoster and postherpetic neuralgia. As a result of these symptoms, the patient was seen and treated by medical providers and was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). The patient also experience mental and emotional distress due to resulting physical limitations and seriousness of the patient's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient have suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events were considered as not recovered/not resolved. The reporter considered the events were related to zoster vaccine live (ZOSTAVAX).  The lawyer considered the events to be disability.
One hour after injection arm pain, fever, chills, body ache, headache Next day arm color and texture around site changing, all previous symptoms remain 3 days after fatigue and pallor  4 days after rash and discoloration forming around injection site
12 HOUR LOW GRADE FEVER OF AROUND 100. HEADACHE AROUND 8 PM. LOSS OF APPETITE, THREE SEPARATE SEIZURES AT 3PM, 6PM AND 8PM ALL HAD STARING SOMETIMES JERKING, AND INCONTINENCE.   RED SPOTS ON FACE AND TRUNK THAT LASTED AROUND 6 HOURS THE NEXT DAY ON 9/27/2015.
Booster Moderna dose administered two days after expiration date.; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Booster Moderna dose administered two days after expiration date.) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A092621) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021 at 4:59 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021 at 4:59 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Booster Moderna dose administered two days after expiration date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Booster Moderna dose administered two days after expiration date.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had not tested positive for COVID-19. No concomitant medications were reported.  Treatment information was not provided. The vaccine was placed in the refrigerator on 30-Aug-2021. No known adverse effects were reported.  The dose of the booster dose was reported as 0.5.   This case was linked to MOD-2022-508128 (Patient Link).
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in an unspecified number of adult patients who received SHINGRIX for prophylaxis. On an unknown date, the patients received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patients experienced influenza-like symptoms, fever and pain. On an unknown date, the outcome of the influenza-like symptoms, fever and pain were unknown. It was unknown if the reporter considered the influenza-like symptoms, fever and pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group was not reported but was captured as adult as per vaccine indication. It was reported that lot of patients experienced reactions to SHINGRIX vaccine such as flu like reactions, fever and pain. The reporter did not know the specific details about the patients and no further details were provided.
got so sick a couple days later; Initial information received on 14-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who experienced got so sick a couple days later after receiving vaccine INFLUENZA VACCINE.   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, dose, formulation, route,lot number not reported) in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious event got so sick a couple days later (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (illness).  At time of reporting, the outcome was Unknown for the event.
vaccination site burning; vaccination site pain; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain) and VACCINATION SITE PAIN (vaccination site burning) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriasis.    Concurrent medical conditions included Psoriasis. Concomitant products included HYDROCORTISONE and LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETRIZINE HYDROCHLORIDE) for an unknown indication.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg. In February 2021, the patient experienced VACCINATION SITE PAIN (vaccination site pain). On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site burning). At the time of the report, VACCINATION SITE PAIN (vaccination site pain) and VACCINATION SITE PAIN (vaccination site burning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered VACCINATION SITE PAIN (vaccination site pain) and VACCINATION SITE PAIN (vaccination site burning) to be not related.
Headache & NauseaVomiting Narrative:  Developed headache and nausea following administration of covid vaccine. Resolved by 1/3/21.
3 hours after immunization, patient had signs and symptoms of soreness throughout body, nausea, vomiting, paleness, diaphresis, and chills. Signs and symptoms lasted approximately 24 hours. Pt stated she had taken Tylenol shortly after signs and symptoms started.
Pt reported fatigue; This non-serious case was reported by a consumer via sales rep and described the occurrence of fatigue in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included MODERNA COVID VACCINE with an associated reaction of fatigue.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fatigue (Verbatim: Pt reported fatigue). The outcome of the fatigue was resolved (duration 24 hrs).   It was unknown if the reporter considered the fatigue to be related to Shingrix.     It was unknown if the company considered the fatigue to be related to Shingrix.   Additional Information: GSK Receipt Date: 27-JUL-2023 The patient self-reported this case. She had fatigue similar to experience with Moderna Covid vaccine.  It was resolved within 24 hours. The reporter denied consent to follow-up.
Received the first injection of Moderna on 12/23/20. On 12/30/20 started with a red itchy rash that was warm to the touch. Went to urgent care that evening and was diagnosed with cellulitis and given a prescription for Keflex. Went back to urgent care on 12/31/20 because the cellulitis had spread and for an allergic reaction to the Keflex. The provider I saw the second time did not change the antibiotic because she felt it hadn't had enough of a dose. Went back again on 01/01/21 due to the rash was still spreading. The provider saw changed the antibiotic and said patient had a mixed medication reaction to the Keflex. The cellulitis has since cleared up.
Febrile seizure lasting 2 1/2 min fever 105 degrees.  Went to ER.
what looked like a case of the measles; This spontaneous case was reported by a consumer and describes the occurrence of RASH MORBILLIFORM (what looked like a case of the measles) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MORBILLIFORM (what looked like a case of the measles). At the time of the report, RASH MORBILLIFORM (what looked like a case of the measles) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Likely comorbidities that were related to death was End Stage Renal Disease
Patient was given a HPV injection and within seconds she fell over with loss of consciousness and jerking movements.  Fell off of exam table.  Pt. was taken to the ED and treated for a nasal laceration, eye abrasion and x-rays.
Pain at injection site; redness at injection site; swelling at injection site; hard lump at injection site; warmth at injection site; This is a spontaneous report from a contactable consumer (patient).   A 73-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot Number: EN6205 ), via an unspecified route of administration, administered in right arm on 27Feb2021 14:00 (at the age of 73-years-old) as dose 1, single for covid-19 immunization.  Medical history included blood pressure and cardiac murmur. Concomitant medications included nebivolol hydrochloride (BYSTOLIC); rosuvastatin (ROSUVASTATIN) and ascorbic acid, betacarotene, biotin, calcium, chromium, colecalciferol, copper, folic acid, iodine, iron, lycopene, magnesium, manganese, nicotinamide, pantothenic acid, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, vitamin b1 nos, vitamin b12 nos, vitamin e nos, xantofyl, zinc (CENTRUM SILVER [ASCORBIC ACID;BETACAROTENE; BIOTIN; CALCIUM;CHROMIUM;COLECALCIFEROL;COPPER;FOLIC ACID;IODINE;IRON;LYCOPENE; MAGNESIUM; MANGANESE; NICOTINAMIDE;PANTOTHENIC ACID;PHOSPHORUS; PHYTOMENADIONE; POTASSIUM;PYRIDOXINE HYDROCHLORIDE; RETINOL; RIBOFLAVIN) . The patient previously took keflex [cefalexin monohydrate] and experienced allergy.  Prior to vaccination, the patient was not pregnant, not diagnosed with COVID-19. Since the vaccination, has the patient has not been tested for COVID-19. The patient experienced pain, redness, swelling, hard lump, and warmth at injection site 27Feb2021. No treatment was taken for the events. The outcome of the events was recovered.  No follow-up attempts are possible. No further information is expected.
Chest pain with increased heart rate to approx. 130 beats/min. 3 liters of NS, Benadryl, Zofran, Toradol, and Dilaudid given. Labs drawn with elevated D-Dimer, normal cardiac enzymes. CT Scan, series of EKGs.
Information has been received from a physician concerning a 62 days old female who on an unspecified date was vaccinated with the first dose of rotavirus vaccine (human-bovine). Subsequently the patient experienced 12 hours worth of diarrhea. Subsequently, the patient recovered. The patient sought unspecified medical attention. There was no product quality complaint involved. Additional information has been requested.
started to experience fever of 100.4 temperature; This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (started to experience fever of 100.4 temperature) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced PYREXIA (started to experience fever of 100.4 temperature). At the time of the report, PYREXIA (started to experience fever of 100.4 temperature) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2022, Body temperature: 100.4 (High) Temperature increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-106992 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-106992:Wife case
1st soreness- immediately, 2nd fatigue and headache within hour, 3rd- bump and itching within 7 days, 4- rash , birthmark extending from shot location to the bicep around 2x3 inches in size & muscle pain with rash in that area.
By November 1, 2020 she was itching unusually all over. This progressively worsened until her diagnosis of Bullous Pemphigoid in Mid-December. After taking steroids for the Bullous Pemphigoid she began falling often and not being able to stand up at all or get out of bed at all - off and on. By December 26 she was unable to leave her bed at all and still is in that state.
Pain in the right hip and right groin.; Pain in the right hip and right groin.; This is a spontaneous report from a contactable female Nurse. A female patient (Age: 85; Unit: Unknown) of an unspecified age received first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration on 29Jan2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient reported her symptoms as pain in the right hip and right groin, also stated that she did not have these symptoms before the vaccine and is wanting to know if symptoms were related to the vaccine. The clinical outcome of events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Headache, Myalgia, MUSCLE PAIN AT INJECTION SITE, BODY ACHES Narrative:
A week after the vaccine, I started getting cold symptoms, sinus infection, and chest cold. I had to go to the doctor because I have asthma and was prescribed prednisone. Once, I was better, a week later I would have the same symptoms and then was prescribed prednisone and Symbicort. I am still under doctors care.